FGF basic (120-125) is a conserved fragment from multiple mammals used to explore structural determinants in fibroblast growth factor pathways. Its short sequence supports mapping of heparin-binding motifs and interaction interfaces. Researchers evaluate its flexibility to dissect receptor-association properties. The peptide aids comparative growth-factor structural studies.
CAT No: B06004
CAS No:152051-61-1
Synonyms/Alias:152051-61-1;bFGF (119-126);(2S)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoyl]amino]-4-methylpentanoic acid;FGF basic (119-126) (human, mouse, rabbit, rat);FGF basic (119-126) (human, bovine, ovine, rabbit);HY-P5321;DA-53170;FF108562;CS-0881168;H-Lys-Arg-Thr-Gly-Gln-Tyr-Lys-Leu-OH; H-KRTGQYKL-OH;
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More